March 26, 2024
Session Chair: Dr. Jérôme Van Biervliet (VIB - Managing Director)
Genetic discoveries at the basis of neurodegenerative brain disease therapies
Dr. Rosa Rademakers - VIB Center for Molecular Neurology – University of Antwerp
Pharma shifts: How to organise for Personal Medicines?
Ir. Bart Van Waeyenberge – EU CAR-T Program Lead, Board of Directors Janssen Pharmaceutica NV
From basic enzymology to new medicines
Prof. dr. Chris Schofield - Dep. Chemistry - University of Oxford